tiprankstipranks
Trending News
More News >
Halozyme: Bristol Myers receives positive CHMP opinion for Opdivo/Enhanze
PremiumThe FlyHalozyme: Bristol Myers receives positive CHMP opinion for Opdivo/Enhanze
1M ago
Halozyme Announces Retirement of Chief Technical Officer
Premium
Company Announcements
Halozyme Announces Retirement of Chief Technical Officer
1M ago
Buy Rating for Halozyme: Potential Revenue Boost from Patent Dispute and Licensing Opportunities
Premium
Ratings
Buy Rating for Halozyme: Potential Revenue Boost from Patent Dispute and Licensing Opportunities
2M ago
Positive Outlook and Strategic Growth: Brendan Smith’s Buy Rating on Halozyme
PremiumRatingsPositive Outlook and Strategic Growth: Brendan Smith’s Buy Rating on Halozyme
2M ago
Halozyme reports Q4 EPS $1.06, consensus $1.16
Premium
The Fly
Halozyme reports Q4 EPS $1.06, consensus $1.16
2M ago
Halozyme backs FY25 EPS view of $4.95-$5.35, consensus $5.05
Premium
The Fly
Halozyme backs FY25 EPS view of $4.95-$5.35, consensus $5.05
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100